JPS52102419A - Lactic acid producing bacillus preparation - Google Patents

Lactic acid producing bacillus preparation

Info

Publication number
JPS52102419A
JPS52102419A JP1922676A JP1922676A JPS52102419A JP S52102419 A JPS52102419 A JP S52102419A JP 1922676 A JP1922676 A JP 1922676A JP 1922676 A JP1922676 A JP 1922676A JP S52102419 A JPS52102419 A JP S52102419A
Authority
JP
Japan
Prior art keywords
present
preparation
pathogenic
lactobacillus
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1922676A
Other languages
English (en)
Other versions
JPS6234731B2 (ja
Inventor
Kousei Hata
Tadatsugu Hata
Toshiyuki Maruoka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikenkai
Original Assignee
Seikenkai
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikenkai filed Critical Seikenkai
Priority to JP1922676A priority Critical patent/JPS52102419A/ja
Publication of JPS52102419A publication Critical patent/JPS52102419A/ja
Priority to US06/085,349 priority patent/US4314995A/en
Publication of JPS6234731B2 publication Critical patent/JPS6234731B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP1922676A 1976-02-23 1976-02-23 Lactic acid producing bacillus preparation Granted JPS52102419A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP1922676A JPS52102419A (en) 1976-02-23 1976-02-23 Lactic acid producing bacillus preparation
US06/085,349 US4314995A (en) 1976-02-23 1979-10-16 Pharmaceutical lactobacillus preparations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1922676A JPS52102419A (en) 1976-02-23 1976-02-23 Lactic acid producing bacillus preparation

Publications (2)

Publication Number Publication Date
JPS52102419A true JPS52102419A (en) 1977-08-27
JPS6234731B2 JPS6234731B2 (ja) 1987-07-28

Family

ID=11993451

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1922676A Granted JPS52102419A (en) 1976-02-23 1976-02-23 Lactic acid producing bacillus preparation

Country Status (2)

Country Link
US (1) US4314995A (ja)
JP (1) JPS52102419A (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238478A (en) * 1977-12-23 1980-12-09 Ljubinko Stojkovic Heterovaccine against the trichomonas syndrome, and process for its preparation
WO2005012503A1 (ja) * 2003-07-30 2005-02-10 Bhph Company Limited 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5911177A (ja) * 1982-07-12 1984-01-20 Seikenkai 新規乳酸桿菌
US5135739A (en) * 1983-02-15 1992-08-04 Kitasato Kenkyusho Non-cariogenic composition and drink
JPS60149527A (ja) * 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
SE463598B (sv) * 1984-11-08 1990-12-17 Chemical Dynamics Sweden Ab Preparat, avsett att oeka vidhaeftningen av bakterier till mag-tarmkanalen hos maenniskor och djur, samt ett framstaellningsfoerfarande foer detta
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
WO1991005850A1 (en) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Bacterium strain lactobacillus plantarum 38 for production of a bacterial biological preparation
WO1991005852A1 (en) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Bacterium strain lactobacillus fermetum 39 for production of a bacterial biological preparation
US5458875A (en) * 1990-06-15 1995-10-17 Biogaia Ab In ovo method for delivering Lactobacillus reuteri to the gastrointestinal tract of poultry
MX9200354A (es) * 1991-01-28 1993-08-01 Biogaia Biolog Ab Metodo para administrar microorganismos directos de alimentacion a aves, en el huevo
WO1993002558A1 (en) * 1991-08-01 1993-02-18 Biogaia Biologics Ab Method and formulation for reducing microbial populations
EP0577904B1 (fr) * 1992-07-06 1997-05-14 Societe Des Produits Nestle S.A. Bactérie lactique
ATE161181T1 (de) * 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
RU2031586C1 (ru) 1993-02-05 1995-03-27 Тамара Георгиевна Извекова Биологически активный кисломолочный продукт "ацидолакт-наринэ" и способ его получения
US6156320A (en) * 1993-02-05 2000-12-05 Harry Parsekian Fermented milk nutraceuticals
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ES2255730T3 (es) * 1997-04-18 2006-07-01 Ganeden Biotech, Inc. Utilizacion topica de esporas de bacilos probioticos para prevenir o tratar las infecciones microbianas.
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US6830750B1 (en) 1998-10-01 2004-12-14 Probi Ab Reduction of oxidative stress factors with Lactobacillus plantarum
JP4193269B2 (ja) 1999-03-04 2008-12-10 ビーエイチピーエイチ カンパニーリミテッド 新規な生体浄化活性型乳酸菌製剤
US6767537B2 (en) * 2000-05-26 2004-07-27 Phil Arnold Nicolay Composition and method for the treatment of sinusitis
US7214370B2 (en) 2000-12-18 2007-05-08 Probiohealth, Llc Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
IL156490A0 (en) 2000-12-18 2004-01-04 Probiohealth Probiotic compounds derived from lactobacillus casei strain ke01
US20050100559A1 (en) * 2003-11-07 2005-05-12 The Procter & Gamble Company Stabilized compositions comprising a probiotic
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
GB0330009D0 (en) * 2003-12-24 2004-01-28 Ferrosan As Probiotic tablet formulations
JP2005192950A (ja) * 2004-01-09 2005-07-21 Ajinomoto Co Inc 微生物乾燥菌体を有効成分とする脱臭剤及び脱臭方法
US20060003454A1 (en) * 2004-07-02 2006-01-05 Conjugon, Inc. Non-dividing donor cells for gene transfer
US20060270040A1 (en) * 2005-05-26 2006-11-30 Conjugon, Inc. Compositions and methods for treating tissue
AU2006253006B8 (en) * 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
JP4938006B2 (ja) * 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
US20070286813A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
EP2124966B1 (en) 2007-02-01 2015-09-09 IAMS Europe B.V. Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP3060225B1 (en) * 2013-10-25 2024-06-19 NCH Corporation Delivery system and probiotic composition for animals
MY195765A (en) 2013-10-25 2023-02-10 Nch Corp Delivery System and Probiotic Composition for Animals and Plants
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
WO2019169179A1 (en) * 2018-02-28 2019-09-06 Shafer Kim Augmenting efficacy of cancer therapies using probiotic based compositions
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
US11576937B2 (en) 2020-02-06 2023-02-14 Nch Corporation Method of reducing gut inflammation reduction in humans by consuming a heated probiotic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1729752A (en) * 1926-02-23 1929-10-01 George T Southgate Deodorant composition
US2027374A (en) * 1932-05-03 1936-01-14 Ora S Fowler Mouth treating composition
US2944941A (en) * 1957-12-23 1960-07-12 Vaxico Inc Method and dentifrice for reducing gingival inflammation
FR1185M (fr) * 1961-03-03 1962-03-19 Ile De Rech S Scient Et Ind So Médicament a base de colibacilles non pathogenes vivants.
FR3626M (fr) * 1963-11-13 1965-10-18 Lucien Nouvel Médicament pour affections intestinales.
DK127268A (ja) * 1970-01-12 1900-01-01
US3957974A (en) * 1974-11-05 1976-05-18 Seikenkai Method for deodorization of excrements

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4238478A (en) * 1977-12-23 1980-12-09 Ljubinko Stojkovic Heterovaccine against the trichomonas syndrome, and process for its preparation
WO2005012503A1 (ja) * 2003-07-30 2005-02-10 Bhph Company Limited 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤
JPWO2005012503A1 (ja) * 2003-07-30 2007-09-27 ビーエイチピーエイチ カンパニーリミテッド 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤
US7863033B2 (en) 2003-07-30 2011-01-04 Bhph Company Limited Lactobacillus living body activating Lactobacillus preparation and preventive or therapeutic agent for living body infection
JP4661593B2 (ja) * 2003-07-30 2011-03-30 ビーエイチピーエイチ カンパニーリミテッド 新規乳酸菌並びに生体賦活型乳酸菌製剤及び生体に対する感染症の予防剤と治療剤

Also Published As

Publication number Publication date
JPS6234731B2 (ja) 1987-07-28
US4314995A (en) 1982-02-09

Similar Documents

Publication Publication Date Title
JPS52102419A (en) Lactic acid producing bacillus preparation
Hall et al. Pseudomonas aeruginosa in dermatology
Rebora et al. Experimental infection with Candida albicans
ATE95060T1 (de) Verwendung von c-22 bis c-26-aliphatischen alkoholen zur behandlung entzuendlicher und viraler hauterkrankungen.
CA2283280A1 (en) Reovirus for the treatment of neoplasia
IL137848A0 (en) Indole-3-propionic acids, salts and esters thereof used as medicaments
NO821832L (no) Fremgangsmaate for fremstilling av allergenholdige kapsler
BE764116A (fr) Nouveaux esters d'acide phosphorique, leur procede de preparation et leur application comme pesticides
ATE243030T1 (de) Orale zubereitung zur prophylaktischen/therapeutischen behandlung von helicobactor sp. infektionen
ES8705229A1 (es) Procedimiento para la obtencion de una preparacion para aumentar la adhesion de bacterias al estomago e intestinos de seres humanos y animales
ES2002398A6 (es) Procedimiento para preparar nuevas enolamidas
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
FR2358160A1 (fr) Produit destine a declencher la parturition, a faciliter la fecondation et a augmenter la lactation chez la femme et chez les mammiferes, notamment le betail
JPS6490126A (en) Antiinflammatory medicine having two chain rna
FR2333807A1 (fr) Nouveaux derives d'acide fusidique, utiles notamment comme antibacterien en medecine humaine et veterinaire et leur procede de preparation
CN115607577A (zh) 一种具有缓解口腔炎症功效的益生菌剂及其制备方法和应用
SE9704584L (sv) Framställning av konjugerad linolsyra
KR910000146A (ko) 동결- 건조된 조성물 및 그 제조 방법
BRPI0413008B1 (pt) Preparation of lactobacillos having a specimen of lactobacillus casei ferm bp-10059 (ferm p-19443) and preventive or therapeutic agent against human, animal and plant infections having a specimen of lactobacillus casei ferm bp-10059 (ferm p-19443)
ATE101042T1 (de) Bakterielle zubereitung fuer die prophylaxe und behandlung von entzuendungen und allergischen beschwerden.
Fuller et al. Aortic connective tissue changes in miniature pigs fed a lipid-rich diet
KR101731569B1 (ko) 으름덩굴 추출물을 유효성분으로 포함하는 구강세균 독성에 의한 염증을 예방, 개선 또는 치료하는 조성물
DE69918152D1 (de) Behandlung von verdauungsstörungen
GB1585863A (en) Pharmaceutical lactobacillus preparations
JPS5238013A (en) Sanitary treatment of materials used in contact with the skin